For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
News Release
#NeverNeeded Regulation Report: Deploy Rational Science-Based Policies for Medical Plant Sterilization
After an EPA program produced a highly flawed assessment in 2016 that vastly overstated the risk of Ethylene Oxide (EtO), a critical gas used for…
Study
Deploy Rational Science-Based Policies for Medical Plant Sterilization
Several medical supply sterilization plants have shut down during the past year because of unwarranted fearmongering about ethylene oxide (EtO), a gas used to sterilize…
National Review
Let the Doctors Work
Buried in the recent announcement by the Bureau of Economic Analysis that real gross domestic product (GDP) decreased at an annual rate of 4.8 percent in the first…
Blog
A New Approach to COVID-19 Response
The new coronavirus—SARS-CoV-2, which causes the disease COVID-19—is here to stay until either a vaccine or herd immunity limits the number of people susceptible to…
News Release
#Neverneeded Regulation Report: CDC, FDA Response to COVID-19 Hindered by Mission Creep
The nation’s top federal agencies tasked with protecting public health have been increasingly distracted over recent years by dubious priorities having nothing to do with…
Study
Narrow the Focus of the Centers for Disease Control and Prevention and Food and Drug Administration
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) may well have taken their eye off the ball by…